Avner Fink

680 total citations
14 papers, 430 citations indexed

About

Avner Fink is a scholar working on Molecular Biology, Immunology and Microbiology. According to data from OpenAlex, Avner Fink has authored 14 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Microbiology. Recurrent topics in Avner Fink's work include Immune Response and Inflammation (4 papers), Bacteriophages and microbial interactions (3 papers) and Antimicrobial Peptides and Activities (3 papers). Avner Fink is often cited by papers focused on Immune Response and Inflammation (4 papers), Bacteriophages and microbial interactions (3 papers) and Antimicrobial Peptides and Activities (3 papers). Avner Fink collaborates with scholars based in Israel, United States and Italy. Avner Fink's co-authors include Yechiel Shai, Eliran Moshe Reuven, Arik Makovitzki, Yechiel Shai, Neta Sal‐Man, Doron Gerber, Dennis L. Kasper, Nihal A. Okan, Giuseppe Stefanetti and P.C. Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and Blood.

In The Last Decade

Avner Fink

14 papers receiving 423 citations

Peers

Avner Fink
Avner Fink
Citations per year, relative to Avner Fink Avner Fink (= 1×) peers Christopher Oelkrug

Countries citing papers authored by Avner Fink

Since Specialization
Citations

This map shows the geographic impact of Avner Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avner Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avner Fink more than expected).

Fields of papers citing papers by Avner Fink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avner Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avner Fink. The network helps show where Avner Fink may publish in the future.

Co-authorship network of co-authors of Avner Fink

This figure shows the co-authorship network connecting the top 25 collaborators of Avner Fink. A scholar is included among the top collaborators of Avner Fink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avner Fink. Avner Fink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Fink, Avner, et al.. (2024). Development of Nontoxic Peptides for Lipopolysaccharide Neutralization and Sepsis Treatment. ACS Pharmacology & Translational Science. 7(6). 1795–1806. 1 indexed citations
2.
Fink, Avner, et al.. (2021). Immunity in acute myeloid leukemia: Where the immune response and targeted therapy meet. European Journal of Immunology. 52(1). 34–43. 4 indexed citations
3.
Stefanetti, Giuseppe, et al.. (2019). Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies toFrancisella tularensis. Proceedings of the National Academy of Sciences. 116(14). 7062–7070. 28 indexed citations
4.
Fink, Avner, et al.. (2017). Type I interferon signaling restrains IL-10R+ colonic macrophages and dendritic cells and leads to more severe Salmonella colitis. PLoS ONE. 12(11). e0188600–e0188600. 6 indexed citations
5.
Ben‐Neriah, Yinon, Avanthika Venkatachalam, Avner Fink, et al.. (2017). Targeting the Transcriptional Addiction of Leukemia Stem Cells By a New Class of Protein Kinase Inhibitors. Blood. 130(Suppl_1). 812–812. 1 indexed citations
6.
Aychek, Tegest, Avner Fink, Ziv Porat, et al.. (2016). Neutralization of pro‐inflammatory monocytes by targeting TLR2 dimerization ameliorates colitis. The EMBO Journal. 35(6). 685–698. 34 indexed citations
7.
Fink, Avner, Musa A. Hassan, Nihal A. Okan, et al.. (2016). Early Interactions of Murine Macrophages with Francisella tularensis Map to Mouse Chromosome 19. mBio. 7(2). e02243–e02243. 5 indexed citations
8.
Reuven, Eliran Moshe, Avner Fink, & Yechiel Shai. (2014). Regulation of innate immune responses by transmembrane interactions: Lessons from the TLR family. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1838(6). 1586–1593. 86 indexed citations
9.
Okan, Nihal A., et al.. (2013). Kdo Hydrolase Is Required for Francisella tularensis Virulence and Evasion of TLR2-Mediated Innate Immunity. mBio. 4(1). e00638–12. 23 indexed citations
10.
Fink, Avner, Eliran Moshe Reuven, Christopher J. Arnusch, et al.. (2013). Assembly of the TLR2/6 Transmembrane Domains Is Essential for Activation and Is a Target for Prevention of Sepsis. The Journal of Immunology. 190(12). 6410–6422. 26 indexed citations
11.
Fink, Avner, Neta Sal‐Man, Doron Gerber, & Yechiel Shai. (2011). Transmembrane domains interactions within the membrane milieu: Principles, advances and challenges. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1818(4). 974–983. 106 indexed citations
12.
Makovitzki, Arik, Avner Fink, & Yechiel Shai. (2009). Suppression of Human Solid Tumor Growth in Mice by Intratumor and Systemic Inoculation of Histidine-Rich and pH-Dependent Host Defense–like Lytic Peptides. Cancer Research. 69(8). 3458–3463. 90 indexed citations
13.
Fink, Avner, et al.. (1980). Unscheduled DNA synthesis in cultured ataxia telangiectasia fibroblast-like cells. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 72(2). 245–249. 15 indexed citations
14.
Rotter, Varda, Avner Fink, & Nathan Trainin. (1978). In vitro allogeneic response of human lymphocytes dependent upon dialyzable plasma components and a thymic hormone, THF. Cellular Immunology. 36(2). 242–250. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026